TD Asset Management Inc Acquires 14,675 Shares of GE HealthCare Technologies Inc. $GEHC

TD Asset Management Inc grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 377,043 shares of the company’s stock after buying an additional 14,675 shares during the quarter. TD Asset Management Inc’s holdings in GE HealthCare Technologies were worth $28,316,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in GEHC. Mufg Securities Americas Inc. lifted its stake in shares of GE HealthCare Technologies by 21.3% in the 3rd quarter. Mufg Securities Americas Inc. now owns 12,312 shares of the company’s stock valued at $925,000 after purchasing an additional 2,164 shares during the last quarter. Compound Planning Inc. bought a new position in shares of GE HealthCare Technologies during the third quarter valued at approximately $202,000. EverSource Wealth Advisors LLC raised its holdings in shares of GE HealthCare Technologies by 16.2% in the third quarter. EverSource Wealth Advisors LLC now owns 2,898 shares of the company’s stock worth $218,000 after buying an additional 405 shares during the period. Legacy Financial Advisors Inc. lifted its stake in shares of GE HealthCare Technologies by 18.8% during the 3rd quarter. Legacy Financial Advisors Inc. now owns 11,466 shares of the company’s stock worth $861,000 after acquiring an additional 1,813 shares during the last quarter. Finally, Aries Wealth Management purchased a new position in GE HealthCare Technologies during the 3rd quarter valued at $206,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $84.27 on Friday. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $90.26. The company has a market cap of $38.41 billion, a PE ratio of 18.48, a P/E/G ratio of 1.85 and a beta of 1.08. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The business has a 50-day simple moving average of $82.38 and a two-hundred day simple moving average of $78.44.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. During the same period last year, the firm posted $1.45 EPS. GE HealthCare Technologies’s revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is presently 3.07%.

Analysts Set New Price Targets

GEHC has been the subject of several research analyst reports. Citigroup lifted their target price on GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. The Goldman Sachs Group reiterated a “buy” rating and set a $98.00 price objective on shares of GE HealthCare Technologies in a report on Friday, January 9th. Wells Fargo & Company boosted their target price on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Finally, Bank of America boosted their price objective on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research note on Monday, January 5th. Seven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.